BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27802061)

  • 1. The importance of correctly timing cancer immunotherapy.
    Beyranvand Nejad E; Welters MJ; Arens R; van der Burg SH
    Expert Opin Biol Ther; 2017 Jan; 17(1):87-103. PubMed ID: 27802061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?
    Zöller M
    Technol Cancer Res Treat; 2003 Jun; 2(3):237-60. PubMed ID: 12779354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological tumor therapy].
    Dietrich K; Theobald M
    Internist (Berl); 2015 Aug; 56(8):907-16; quiz 917. PubMed ID: 26187335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential beneficial effects of drugs on the immune response to vaccination.
    Liu WM; Dalgleish AG
    Semin Oncol; 2012 Jun; 39(3):340-7. PubMed ID: 22595056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of cancer].
    Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
    Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer vaccines. Any future?
    Myc LA; Gamian A; Myc A
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
    Yu WD; Sun G; Li J; Xu J; Wang X
    Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of cancer: from vision to standard clinical practice.
    Huber CH; Wölfel T
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):367-74. PubMed ID: 15067541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 10. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of cancer immunotherapies.
    Gao J; Bernatchez C; Sharma P; Radvanyi LG; Hwu P
    Trends Immunol; 2013 Feb; 34(2):90-8. PubMed ID: 23031830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action for immunotherapy drugs].
    Tahara H
    Nihon Rinsho; 2012 Dec; 70(12):2066-72. PubMed ID: 23259376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.
    Locy H; de Mey S; de Mey W; De Ridder M; Thielemans K; Maenhout SK
    Front Immunol; 2018; 9():2909. PubMed ID: 30619273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-based vaccines for cancer therapy.
    Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
    Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.
    Ellmark P; Mangsbo SM; Furebring C; Norlén P; Tötterman TH
    Cancer Immunol Immunother; 2017 Jan; 66(1):1-7. PubMed ID: 27714433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation approaches for tumor vaccination.
    Patel A; Kaufman HL; Disis ML
    Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.